Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.
J Antimicrob Chemother
; 71(2): 314-23, 2016 Feb.
Article
in En
| MEDLINE
| ID: mdl-26604243
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Main subject:
Tuberculosis, Multidrug-Resistant
/
Mutation, Missense
/
Fluoroquinolones
/
DNA Gyrase
/
Mycobacterium tuberculosis
/
Antitubercular Agents
Type of study:
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
Asia
Language:
En
Journal:
J Antimicrob Chemother
Year:
2016
Type:
Article
Affiliation country:
Belgium